Minor Variant Detection in Amplicons using 454 Massive Parallel Pyrosequencing: Experiences and Considerations for Successful Applications

Abstract

Ultra-deep sequencing (UDS) of amplicons is a major application for next-generation sequencing technologies, even more so for the 454 Genome Sequencer FLX. Especially for this application, errors that might be introduced during any of the sample processing or data analysis steps should be avoided or at least recognized, as they might lead to aberrant sequence variant calling. Since 454 pyrosequencing relies on PCR-driven target amplification, it is key to differentiate errors introduced during the amplification step from genuine minority variants. Thereto, optimal primer design is imperative because primer selection, primer dimer formation, and nonspecific binding may all affect the quality and outcome of amplicon-based deep sequencing. Also, other intrinsic PCR characteristics including amplification drift and the formation of secondary structures may influence sequencing data quality. We illustrate these phenomena using real life case studies and propose experimental and analytical evidence-based solutions for effective practice. Furthermore, because accuracy of the DNA polymerase is vital for reliable UDS results, a comparative analysis of error profiles from seven different DNA polymerases was performed and experimentally assessed in parallel by 454 sequencing. Finally, intra and interrun variability evaluation of the 454 sequencing protocol revealed highly reproducible results in amplicon-based UDS.

The Human Fetal Glial Cell Line SVG p12 Contains Infectious BK Polyomavirus

“…We cannot fully exclude that some of the fragmented genomes found are due to amplification artifacts caused, for instance, by generation of secondary structures during the amplification prior to pyrosequencing (58) or from the rolling-circle amplification (59). However, the observation of deletion mutants by different methods supports the notion of fragmented genomes.…”

Abundant Drug-Resistant NS3 Mutants Detected by Deep Sequencing in Hepatitis C Virus-Infected Patients Undergoing NS3 Protease Inhibitor Monotherapy

“…All RNA isolations, reverse transcription followed by PCR (RT-PCR) amplifications, and deep sequencing were performed at Virco DBA (Virco, Belgium) (11). Up to 1 ml of patient plasma sample was processed to isolate RNA.…”

“…To maximize the number of input templates and to minimize variation due to PCR drift, each patient RNA sample was divided into 7 aliquots, and 7 parallel RT-PCRs were performed. The addition of 12 distinct 10-nucleotide (nt)-long barcode sequences to the primers allowed the simultaneous processing of amplicons originating from multiple patient samples (11). Each 454 deep-sequencing run included 48 samples.…”

A Novel Approach to Tracking Antigen-Experienced CD4 T Cells into Functional Compartments via Tandem Deep and Shallow TCR Clonotyping

“…AST samples are prepared using 59RACE technology and do not require normalization for PCR bias. In combination with the low error rate of Phusion High-Fidelity DNA polymerase [estimated at 0.11% (15)], these quality control measures limit lowabundance TCR clonotypes introduced by sequencing and PCR error. AST clonotype frequencies were then calculated as a function of the total number of productive clonotypes (using three-point match of V and J gene family and CDR3 sequence) that matched to the International ImMunoGeneTics collaboration (IMGT/GENE-DB) database and were above the 0.17% quality control cut-off described above.…”